Lantheus Holdings (LNTH) Cash & Current Investments (2013 - 2026)

Lantheus Holdings (LNTH) reported Cash & Current Investments of $498.6 million for Q1 2026, down 46.88% year-over-year from $938.5 million in Q1 2025, and up 38.83% quarter-over-quarter from $359.1 million in Q4 2025.

Lantheus Holdings (LNTH) Cash & Current Investments (2013 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 14 years of Cash & Current Investments data on file, last reported at $498.6 million in Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $498.6 million, down 46.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $498.6 million (down 46.88% YoY), and the FY2025 annual result was $359.1 million, down 60.66% from the prior year.
  • Cash & Current Investments rose to $498.6 million in Q1 2026 per LNTH's latest filing, from $359.1 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $938.5 million in Q1 2025 and troughed at $105.4 million in Q1 2022.
  • A 5-year average of $546.5 million and a median of $498.6 million in 2026 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2023 and 2025: Cash & Current Investments jumped 346.93% in 2023, then sank 60.66% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $415.7 million in 2022, then jumped by 71.7% to $713.7 million in 2023, then increased by 27.91% to $912.8 million in 2024, then slumped by 60.66% to $359.1 million in 2025, then soared by 38.83% to $498.6 million in 2026.
  • Business Quant data shows LNTH's Cash & Current Investments at $498.6 million in Q1 2026, $359.1 million in Q4 2025, and $382.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 3.74 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 1.94 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 2.15 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 77.77 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.32 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 428.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 511.86 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 750.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 498.58 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 222.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 498.58 Mn
Dec 31, 2025 359.12 Mn
Sep 30, 2025 382.01 Mn
Jun 30, 2025 695.57 Mn
Mar 31, 2025 938.53 Mn
Dec 31, 2024 912.81 Mn
Sep 30, 2024 866.39 Mn
Jun 30, 2024 757.02 Mn
Mar 31, 2024 718.28 Mn
Dec 31, 2023 713.66 Mn
Sep 30, 2023 614.13 Mn
Jun 30, 2023 414.08 Mn
Mar 31, 2023 470.86 Mn
Dec 31, 2022 415.65 Mn
Sep 30, 2022 257.26 Mn
Jun 30, 2022 171.43 Mn
Mar 31, 2022 105.36 Mn
Dec 31, 2021 98.51 Mn
Sep 30, 2021 91.48 Mn
Jun 30, 2021 91.50 Mn